Biomaterials Market by Type (Metallic, Polymeric, Ceramic, and Natural) and Application, (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders, and Drug Delivery Systems): Global Opportunity Analysis and Industry Forecast, 2021-2030
According to a new report published by Allied Market Research, titled, "Biomaterials Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030," the global biomaterials market size was valued at $64.87 billion in 2020 and is projected to reach $212.40 billion by 2030, registering a CAGR of 12.7% from 2021 to 2030.
Download Sample Report : https://www.alliedmarketresearch.com/request-sample/89
The COVID-19 virus causes illness ranging from common cold to more severe respiratory diseases. The revenue of global biomaterials market also declined in 2020 due to the global economic recession led by the COVID-19 pandemic. For instance, orthopedics implant surgeries and non-essential dental procedures, have been delayed due to the COVID-19 pandemic, which also decreases the demand for biomaterials. Thus, the outbreak of COVID-19 has negatively impacted the biomaterials market.
The biomaterials market is segmented on the basis of type, application, and region. By type, it is bifurcated into metallic, polymeric, ceramic, and natural. Metallic biomaterials are segmented into stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, and silver. Polymeric biomaterials are divided into polymethyl methacrylate (PMMA), polyethylene, polyester, polyvinylchloride, silicone rubber, nylon. Ceramic biomaterials are segmented into calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon, and glass. Natural biomaterials comprise hyaluronic acid, collagen & gelatin, fibrin, cellulose, chitin, alginates, and silk. The metallic segment was the major shareholder in 2020, owing to their high specific strength, high corrosion resistance, and low modulus. In addition, they are highly used in orthopedics, dental, cardiovascular, and neurological permanent and bioresorbable implants, which drive growth of the segment.
Key Market Segments
BY TYPE
Metallic
.Stainless Steel
Titanium and Titanium Alloys
Cobalt-Chrome Alloys
Gold
Silver
Polymeric
Polymethylmethacrylate
Polyethylene
Polyester
Polyvinylchloride
Silicone Rubber
Nylon
Ceramic
Zirconia
Aluminum Oxide
Calcium Sulfate
Carbon
Glass
Natural
Hyaluronic Acid
Collagen and Gelatin
Fibrin
Cellulose
Chitin
Alginates
Silk
BY APPLICATION
Cardiovascular
Dental
Orthopedic
Wound Healing
Plastic Surgery
Ophthalmology
Neurological Disorder
Drug Delivery System
Key Findings Of Study
On the basis of type, the metallic segment held largest share in the global market in 2020.
On the basis of application, the orthopedic segment dominates the global biomaterials market in 2020 and is anticipated to continue this trend during the forecast period.
On the basis of region, North America is expected to experience growth at the highest rate, registering a CAGR of 12.5% during the forecast period.
Request Customization : https://www.alliedmarketresearch.com/request-for-customization/89
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
Vaccine manufacturing is a complex process, wherein effect, safety, and consistency are the most important part for the manufacturers.The factors that propel the growth of the Vaccine Market include increasing government and nongovernment funding for vaccine development, increasing occurrence of diseases, and growing investments by businesses.
The “Conjugate Vaccines” segment led the Vaccine Market in 2017 and is anticipated to maintain its dominance by 2022 due to rising investments by the government of emerging nations and increasing occurrence of infectious diseases.Vaccine Market could be explored based on disease indications as Hepatitis, Influenza, DTP, Pneumococcal Disease, Human Papilloma Virus (HPV), MMR (measles, mumps, and rubella), Rotavirus, Meningococcal Disease, Dengue, Varicella, Polio, and Other Disease Indications.
In addition, North America is followed by Europe and expected to hold second major share in the forecast period owing to increasing government support and accessibility of funding and scheme capital funds for the growth of new vaccines.The key players contributing to the robust growth of the Vaccine Market comprise GlaxoSmithKline Plc., Bavarian Nordic, Astellas Pharma, Inc., Serum Institute of India, CSL Limited, Emergent BioSolutions, Inc., Daiichi Sankyo Company, Limited, Medimmune, Llc (A Subsidiary of AstraZeneca), Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Merck & Co., Inc., Pfizer, Inc., Panacea Biotech, Sanofi Pasteur Sa, and Protein Sciences Corporation.
The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.The report package World Vaccine Markets to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for vaccines in the world.
Along with a global vaccines market report, the package includes country reports from the following countries:Armenia, Australia, Austria, Bangladesh, Belgium, Bolivia, Bosnia Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Latvia, Lebanon, Lithuania, Macedonia, Malawi, Malaysia, Mexico, Moldova, Morocco, Nepal, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Serbia, Singapore, Slovakia, Slovenia, South Korea, Spain, Sri Lanka, Sweden, Switzerland, Tanzania, Thailand, Trinidad and Tobago, Turkey, Ukraine, United Kingdom, United States, Uruguay, VietnamThe research includes historical data from 2011 to 2017 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.
The reports help answer the following questions:- What is the size of the vaccine market in the world and in different countries?- How is the market split into different types of vaccines?- How are the overall market and different product types growing?- How is the market predicted to develop in the future?The latest industry data included in the reports:- Demand for vaccines, 2011-2022- Vaccine market size by product type, 2011-2022- Growth rates of the overall market and different product segments, 2011-2022- Shares of different product segments of the overall market, 2011, 2017, and 2022The market data is given for the following product segments:Human vaccinesVeterinary vaccinesAmong the key reasons to purchase include the following:- Gain an outlook of the historical development, current market situation, and future outlook of the vaccine market in the world to 2022- Track industry developments and identify market opportunities- Plan and develop marketing, market-entry, market expansion, and other business strategies by identifying the key market opportunities and prospects- Save time and money with the readily accessible key market data included in the reports.
Dental Biomaterials Market Research Report, by Type (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials), by Application (Implantology, Prosthodontics, Orthodontics), by End User (Dental Product Manufacturers, Dental Laboratories) - Global Forecast till 2027Market AnalysisThe global dental biomaterials market is anticipated to grow at a 6.2% CAGR between 2018-2023, reveals the new Market Research Future (MRFR) report.
Dental biomaterials, simply put, are natural or fabricated structures that are utilized in dentistry for orthodontics, prosthodontics, implantology, and others.
Such factors, as per the latest Market Research Future report, include the growing awareness about the significance of dental implants, rise in disposable income, rising investments in the dental industry, and growing dental tourism.
Factors pushing the growth of the dental biomaterials market in the region include rising government funding on oral healthcare, rising number of dental procedures, presence of various developed economies, increase in dental hospitals & clinics, growing geriatric population, and increasing use of dental biomaterials for manufacturing implants as well as other dental products.
The dental biomaterials market in the MEA will have a minimal share during the forecast period owing to low healthcare expenditure, lack of awareness, and the presence of poor economies.
Key players have incorporated different strategies for sustaining the competitive environment, such as research and development for advancements in dental biomaterials, product approvals and product launches.TABLE OF CONTENTChapter 1.
